SLC7A11 and rheumatoid arthritis: Experiments with RA-FLSs treated with RSL3 showed decreased expression of solute carrier family 2 member 3 (SLC2A3), FTH1, SLC7A11, and GPX4, thereby inducing ferroptosis along with increased lipid peroxidation and accumulation of ferrous ions [74].